During the past 20 years, *Escherichia coli* sequence type (ST) 131 has emerged as a prevalent vehicle for extended-spectrum β-lactamases (ESBL) worldwide. Particularly prevalent are isolates of the clade ST131 C/H30R, which frequently are associated with urinary tract infections and bacteremia ([@R1],[@R2]). Although the ESBL production of the predominant subgroup ST131 C2/H30Rx is conferred by the CTX-M-15 allele, the emerging subgroup C1 often is associated with other CTX-M alleles, such as CTX-M-14 and CTX-M-27 ([@R3]). An increase in C1/H30R ST131 isolates was initially reported among clinical isolates in Japan; most of those were identified as members of the recently defined clade C1-M27 (90% of C1/H30R) ([@R3]). More recently, a dramatic rise from 0% to 65% in the incidence of ST131 C1/H30R *bla*~CTX-M-27~ isolates in the fecal carriage of children in France during 2010--2015 was reported ([@R4]). In addition, ST131 isolates harboring *bla*~CTX-M-27~ have been reported sporadically from other countries ([@R3]). We examined ESBL-producing isolates from livestock, humans, companion animals, food, and the environment during 2009--2016 in Germany for the CTX-M-27 allele.

We analyzed a representative subset of 953 sequenced isolates from a collection of 4,386 nonrepetitive ESBL-producing *E. coli*, which were obtained through 2 national research networks investigating the incidence of antimicrobial resistance: ESBL and Fluoroquinolone Resistance in Enterobacteriaceae (RESET) and German Center for Infection Research (DZIF) in Germany ([Technical Appendix 1](#SD1){ref-type="local-data"}). In silico multilocus sequence typing (MLST) identified 159 (17%) of the 953 isolates as ST131 ([Technical Appendix 2](#SD1){ref-type="local-data"}). The most prevalent ESBL genes in the studied isolates were *bla*~CTX-M-15~ (73 \[46%\]), followed by *bla*~CTX-M-27~ (24 \[15%\]), *bla*~CTX-M-1~ (18 \[11%\]), *bla*~CTX-M-14~ (15 \[9%\]), and others (*bla*~CTX-M-3/11/17/24/36/47~) (10 \[6%\]).

Because recent reports have documented an increase in the number of C1-M27 clade isolates in Japan and France, we investigated *bla*~CTX-M-27~--encoding ST131 isolates in more detail. All ST131 isolates with *bla*~CTX-M-27~ were of serogroup O25b and harbored a *fimH*30 allele, except for 1 isolate that was of serogroup O16 and carried a *fim*H41 allele. Recently, the M27PP1 prophage-like region was defined as a specific marker for C1-M27 clade ([@R3],[@R4]). This region was present in 23 of 24 *bla*~CTX-M-27~--harboring isolates. Phylogenomic analysis revealed that these 23 isolates belong to clade C1/H30R ([Technical Appendix 2](#SD1){ref-type="local-data"} Figure).

We identified contigs with F1:A2:B20 plasmid replicons in sequences from 20 of 24 isolates; the remaining isolates harbored contigs with F1:A6:B20, F1:A2:B20, F1:A2:B-, and F29:A-:B10 plasmid incompatibility groups. We sequenced the genome of 1 representative isolate (H105) to completion (GenBank accession numbers: chromosome, CP021454; plasmid, CP021871) and confirmed that the *bla*~CTX-M-27~--encoding contig was indeed part of a plasmid harboring the F1:A2:B20 replicon ([@R5]). This plasmid is highly conserved in isolates of ST131 and is probably ancestral to the C1/H30R clade because it is present in all the *bla*~CTX-M-27~--positive ST131 isolates, regardless of whether they harbor antimicrobial resistance genes ([@R5]).

Core genome phylogenetic comparisons of all C/H30R ST131 isolates, based on alignment to the closed genome of *E. coli* ST131 lineage C1-M27 isolate H105, revealed an average of 292 single-nucleotide polymorphisms (SNPs). In contrast, isolates within the C1-M27 clade were separated by \<100 SNPs. Comparative analyses of 13 isolates reported from Japan showed that these isolates share ≈85% of the genome with those from Germany. Isolates from both countries exhibit an average difference of 59 SNPs, indicating clonality and possible evolution from a single common ancestor ([Technical Appendix 2](#SD1){ref-type="local-data"}). Metadata of the C1-M27 isolates showed 19 of 24 isolates were obtained in 2015 and 2016, indicating recent emergence.

Our results provide evidence for the recent emergence of ST131 subgroup *fim*H30-O25b, clade C1-M27, harboring *bla*~CTX-M-27~, in Germany and reinforce observations made elsewhere. The data suggest an ongoing shift in CTX-M alleles associated with ST131 infections worldwide that now warrants further attention.

###### Technical Appendix 1

Resistance genes from a representative subset of 953 sequenced isolates from a collection of 4,386 nonrepetitive extended-spectrum β-lactamase--producing *Escherichia coli*, Germany.

###### Technical Appendix 2

Whole-genome sequencing and in silico analysis of *bla*~CTX-M-27~--encoding *Escherichia coli*, Germany.
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